Tracking Acinetobacter baumannii in Critical Care Units: Environmental Surveillance and One Health Strategies for AMR Prevention
DOI:
https://doi.org/10.35516/jmj.v59i5.4819Keywords:
Acinetobacter baumannii, Environmental surveillance, antimicrobial resistance, One Health, Critical careAbstract
Acinetobacter baumannii (A. baumannii) is a bacterium causing infections in hospitals, especially in intensive care units (ICUs). This bacterium persists in hospital environments and quickly becomes resistant to medicines. This review details its behavior, spread, and control in hospital care areas, focusing on environmental monitoring and One Health strategies to stop antimicrobial resistance (AMR). We explain methods to sample and grow bacteria for identification, using quantitative PCR and whole-genome sequencing for rapid detection. We discuss data management frameworks and bioinformatics pipelines that help analyze data and visualize bacterial spread. Control measures include careful cleaning, environmental decontamination machines, and antimicrobial stewardship programs. The One Health perspective emphasizes the connection between humans, animals, and nature in controlling bacteria. Challenges include limited lab space, varied data collection methods, and need for new testing approaches. This report suggests future research in metagenomic surveillance, machine learning-driven risk modeling, and pangenome-guided drug discovery. By integrating laboratory, clinical, and environmental science, this report provides a comprehensive plan to control A. baumannii in ICUs and address antimicrobial resistance.
References
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., … Trivedi, K. K. (2016). Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clinical Infectious Diseases, 62(10), e51–e77. https://academic.oup.com/cid/article-abstract/62/10/e51/2462846
Alenazi, T. A., Shaman, M. S. B., Suliman, D. M., Alanazi, T. A., Altawalbeh, S. M., Alshareef, H., Aldeyab, M. A. (2023, February). The impact of multidrug‐resistant Acinetobacter baumannii infection in critically ill patients with or without COVID‐19 infection. In Healthcare (Vol. 11, No. 4, p. 487). MDPI. https://www.mdpi.com/2227-9032/11/4/487
MeysamSarshar*1, Payam Behzadi2, Anna Teresa Palamara 5,6, Daniela Scribano 3,4, and Cecilia Ambrosi 6,7, Acinetobacter baumannii: An Ancient Commensal with Weapons of a Pathogen Pathogens 2021, 10, 387. https://doi.org/10.3390/pathogens10040387
Chang, Y., Jeon, K., Lee, S. M., Cho, Y. J., Kim, Y. S., Chong, Y. P., & Hong, S. B. (2021). The distribution of multidrug-resistant microorganisms and treatment status of hospital-acquired pneumonia/ventilator-associated pneumonia in adult intensive care units: a prospective cohort observational study. Journal of Korean Medical Science, 36(41). https://synapse.koreamed.org/articles/1147938
Comar, M., D’Accolti, M., Cason, C., Soffritti, I., Campisciano, G., Lanzoni, L., … Caselli, E. (2019). Introduction of NGS in environmental surveillance for healthcare-associated infection control. Microorganisms, 7(12), 708. https://www.mdpi.com/2076-2607/7/12/708
Borer, A., Saidel-Odes, L., Riesenberg, K., Eskira, S., Peled, N., Nativ, R., … Sherf, M. (2009). Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infection Control & Hospital Epidemiology, 30(10), 972–976. https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/attributable-mortality-rate-for-carbapenemresistant-klebsiella-pneumoniae-bacteremia/2AD70DA5BBF04419903E384B54081F79
Bartual, S. G., Seifert, H., Hippler, C., Luzon, M. A. D., Wisplinghoff, H., & Rodríguez-Valera, F. (2005). Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. Journal of Clinical Microbiology, 43(9), 4382–4390. https://journals.asm.org/doi/abs/10.1128/jcm.43.9.4382-4390.2005
Ababneh, Q., Abu Laila, S., & Jaradat, Z. (2022). Prevalence, genetic diversity, antibiotic resistance and biofilm formation of Acinetobacter baumannii isolated from urban environments. Journal of Applied Microbiology, 133(6), 3617–3633. https://academic.oup.com/jambio/article-abstract/133/6/3617/6989108
Mohammad Al-Tamimi1, Hadeel Albalawi1, Walaa Isied1, Ahmad Musallam1, Fatima Qazzaz1, Mohammad Azab1, Jumana Abu-raideh1, Nisreen Himsawi1, Joel Vaughan2Gram-Positive Bacterial Infections and Antibiotics Resistance in Jordan: Current Status and Future Perspective Jordan Medical Journal, Volume 56, No.1 2022 DOI: https://doi.org/10.35516/jmj.v56i1.219
Berger, D., Gundermann, G., Sinha, A., Moroi, M., Goyal, N., & Tsai, A. (2022). Review of aerosolized hydrogen peroxide, vaporized hydrogen peroxide, and hydrogen peroxide gas plasma in the decontamination of filtering facepiece respirators. American Journal of Infection Control, 50(2), 203–213. https://www.sciencedirect.com/science/article/pii/S0196655321004314
Ben-Chetrit, E., Wiener-Well, Y., Lesho, E., Kopuit, P., Broyer, C., Bier, L., … Levin, P. D. (2018). An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: long-term impact for the ICU and hospital. Critical Care, 22, 1–10.
https://link.springer.com/article/10.1186/s13054-018-2247-y
Benoit, T., Cloutier, M., Schop, R., Lowerison, M. W., & Khan, I. U. (2020). Comparative assessment of growth media and incubation conditions for enhanced recovery and isolation of Acinetobacter baumannii from aquatic matrices. Journal of Microbiological Methods, 176, 106023. https://www.sciencedirect.com/science/article/pii/S0167701220307399
Bhandari, S., Upreti, M. K., Angbuhang, K. B., Shrestha, B., & Thapa Shrestha, U. (2025). Biofilm formation capacity and carbapenem‐resistance in Acinetobacter-calcoaceticus-baumannii isolated from inpatients in a tertiary care hospital in Nepal. BMC Research Notes, 18(1), 1–9. https://link.springer.com/article/10.1186/s13104-025-07211-5
Bartual, S. G., Seifert, H., Hippler, C., Luzon, M. A. D., Wisplinghoff, H., & Rodríguez-Valera, F. (2005). Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. Journal of Clinical Microbiology, 43(9), 4382–4390. https://journals.asm.org/doi/abs/10.1128/jcm.43.9.4382-4390.2005
Centers for Disease Control and Prevention. (2020). Antibiotic resistance threats in the United States, 2019. Atlanta, GA: US Department of Health and Human Services, CDC; 2019.
Zhang X, Li F, Awan F, Jiang H, Zeng Z and Lv W (2021) Molecular Epidemiology and Clone Transmission of CarbapenemResistant Acinetobacter baumannii in ICU Rooms. Front. Cell. Infect. Microbiol. 11:633817. doi: 10.3389/fcimb.2021.633817
Shelenkov, A.; Akimkin, V.; Mikhaylova, Y. International Clones of High Risk of Acinetobacter Baumannii—Definitions, History, Properties and Perspectives. Microorganisms 2023, 11, 2115. https://doi.org/10.3390/ microorganisms11082115
Thais Martins-Gonçalves,1,2 Julia S. Pimenta,3 Herrison Fontana,2,4 Fernanda Esposito,2,4 Gregory Melocco,2,4 Karine Dantas,2,4 Felipe Vásquez-Ponce,1,2 Floristher E. Carrara,3 Eliana C. Vespero,3 Nilton Lincopan1,2, Acinetobacter baumannii international clone 2 co-producing OXA-23, NDM-1, and ArmA emerging in South America Antimicrobial Agents and Chemotherapy May 2024 Volume 68 Issue 5
Argimón, S., Abudahab, K., Goater, R. J., Fedosejev, A., Bhai, J., Glasner, C., … Aanensen, D. M. (2016). Microreact: visualizing and sharing data for genomic epidemiology and phylogeography. Microbial Genomics, 2(11), e000093. https://www.microbiologyresearch.org/content/journal/mgen/10.1099/mgen.0.000093
Chai, J., Donnelly, T., Wong, T., & Bryce, E. (2018). Environmental sampling of hospital surfaces: assessing methodological quality. Canadian Journal of Infection Control/Revue Canadienne de Prévention des Infections, 33(3). https://ipac-canada.org/photos/custom/pdf/cjicArticleBryce.pdf
Chastre, J., Wolff, M., Fagon, J. Y., Chevret, S., Thomas, F., Wermert, D., … PneumA Trial Group. (2003). Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA, 290(19), 2588–2598. https://jamanetwork.com/journals/jama/article-abstract/197644
Hamid Vaez1*, Mohsen Barani2, Mohsen Khamar2, Zahra Yazdanpour1, Soudabeh Hamedi-Shahraki3Antibiotic Resistance Patterns and Distribution of Extended Spectrum Beta-Lactamases and Different Classes of Integrons Among Pseudomonas aeruginosa Strains Recovered from Various Clinical Samples (J Med J 2025; Vol. 59(1): 105-114) DOI: https://doi.org/10.35516/jmj.v59i1.2546
Cherifi, S., Gerard, M., Arias, S., & Byl, B. (2013). A multicenter quasi-experimental study: impact of a central line infection control program using auditing and performance feedback in five Belgian intensive care units. Antimicrobial Resistance and Infection Control, 2, 33. https://link.springer.com/article/10.1186/2047-2994-2-33
Shanmugapriya Seshatri1, Jaykaran Charan1 Sneha Ambwani1, Vibhor Tak2, Vijaya Lakshmi Nag2, Shoban Babu Varthya1 Frequency of OXA-Type carbapenemases among carbapenem-resistant Acinetobacter baumannii in clinical isolates from adult intensive care unit in India Journal of Laboratory Physicians • Volume 16 • Issue 1 • January-March 2024 doi: 10.1055/s-0043-1771243
Raquel Vosges Caldart1, Erica L Fonseca2/+, Fernanda Freitas2, Luiza Rocha3, Ana Carolina Vicente2Acinetobacter baumannii infections in Amazon Region driven by extensively drug resistant international clones, 2016-2018Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 114: e190232, 2019 doi: 10.1590/0074-02760190232
J. Nowak1, E. Zander1, D. Stefanik1, P. G. Higgins1,2*, I. Roca3, J. Vila3, M. J. McConnell4, J. M. Cisneros4 and H. Seifert1,2 on behalf of the MagicBullet Working Group WP4High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trialJ Antimicrob Chemother 2017; 72: 3277–3282 doi:10.1093/jac/dkx322 Advance Access publication 8 September 2017
Clark, A. E., Kaleta, E. J., Arora, A., & Wolk, D. M. (2013). Matrix-assisted laser desorption ionization–time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology. Clinical Microbiology Reviews, 26(3), 547–603. https://journals.asm.org/doi/abs/10.1128/cmr.00072-12
Apisarnthanarak, A., Pinitchai, U., Warachan, B., Warren, D. K., Khawcharoenporn, T., & Hayden, M. K. (2014). Effectiveness of infection prevention measures featuring advanced source control and environmental cleaning to limit transmission of extremely‐drug resistant Acinetobacter baumannii in a Thai intensive care unit: an analysis before and after extensive flooding. American Journal of Infection Control, 42(2), 116–121. https://www.sciencedirect.com/science/article/pii/S0196655313013072
Cook-Libin, S., Sykes, E. M., Kornelsen, V., & Kumar, A. (2022). Iron acquisition mechanisms and their role in the virulence of Acinetobacter baumannii. Infection and Immunity, 90(10), e00223-22. https://journals.asm.org/doi/abs/10.1128/iai.00223-22
Dallenne, C., Da Costa, A., Decré, D., Favier, C., & Arlet, G. (2010). Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. Journal of Antimicrobial Chemotherapy, 65(3), 490–495. https://academic.oup.com/jac/article-abstract/65/3/490/748889
de Breij, A. (2012). Towards an explanation for the success of Acinetobacter baumannii in the human host. Leiden, Netherlands: Faculty of Medicine Leiden University.
https://scholarlypublications.universiteitleiden.nl/access/item%3A2927075/download
de Morais Oliveira-Tintino, C. D., Muniz, D. F., dos Santos Barbosa, C. R., Silva Pereira, R. L., Begnini, I. M., Rebelo, R. A., … da Silva, T. G. (2023). NorA, Tet(K), MepA, and MsrA efflux pumps in Staphylococcus aureus, their inhibitors and 1,8-naphthyridine sulfonamides. Current Pharmaceutical Design, 29(5), 323–355. https://www.benthamdirect.com/content/journals/cpd/10.2174/1381612829666221212101501
Dekic, S., Hrenovic, J., van Wilpe, E., Venter, C., & Goic-Barisic, I. (2019). Survival of emerging pathogen Acinetobacter baumannii in water environment exposed to different oxygen conditions. Water Science and Technology, 80(8), 1581–1590. https://iwaponline.com/wst/article-abstract/80/8/1581/71322
Diancourt, L., Passet, V., Nemec, A., Dijkshoorn, L., & Brisse, S. (2010). The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLOS One, 5(4), e10034. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010034
Dijkshoorn, L., Nemec, A., & Seifert, H. (2007). An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nature Reviews Microbiology, 5(12), 939–951.
https://www.nature.com/articles/nrmicro1789
Durán-Manuel, E. M., Cruz-Cruz, C., Ibáñez-Cervantes, G., Bravata-Alcantará, J. C., Sosa-Hernandez, O., Delgado-Balbuena, L., … Bello-López, J. M. (2021). Clonal dispersion of Acinetobacter baumannii in an intensive care unit designed to patients COVID-19. The Journal of Infection in Developing Countries, 15(01), 58–68. https://jidc.org/index.php/journal/article/view/13545
Eckardt, P., Canavan, K., Guran, R., George, E., Miller, N., Avendano, D. H., … Ramirez, K. H. G. (2022). Containment of a carbapenem-resistant Acinetobacter baumannii complex outbreak in a COVID-19 intensive care unit. American Journal of Infection Control, 50(5), 477–481.
https://www.sciencedirect.com/science/article/pii/S0196655322000980
Espinal, P., Martí, S., & Vila, J. (2012). Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. Journal of Hospital Infection, 80(1), 56–60. https://www.sciencedirect.com/science/article/pii/S0195670111003458
Evans, B. A., & Amyes, S. G. (2014). OXA β-lactamases. Clinical Microbiology Reviews, 27(2), 241–263. https://journals.asm.org/doi/abs/10.1128/cmr.00117-13
Fabre, V., Secaira, C., Herzig, C., Bancroft, E., Bernachea, M. P., Galarza, L. A., … Quiros, R. E. (2024). Contextual barriers to infection prevention and control program implementation in hospitals in Latin America: a mixed methods evaluation. Antimicrobial Resistance & Infection Control, 13(1), 132.
https://link.springer.com/article/10.1186/s13756-024-01484-4
Fodor, A., Abate, B. A., Deák, P., Fodor, L., Klein, M. G., Makrai, M., … Vozik, D. (2018). An overview of multi-antibiotic resistance in pathogenic bacteria—From selected genetic and evolutionary aspects—A review. Preprint, 2018080036(10.20944). https://www.researchgate.net/profile/Andras-Fodor/publication/326872540_An_Overview_of_Multi-Antibiotic_Resistance_in_Pathogenic_Bacteria_-_From_Selected_Genetic_and_Evolutionary_Aspects_-_A_Review/links/5b8940364585151fd13e26ba/An-Overview-of-Multi-Antibiotic-Resistance-in-Pathogenic-Bacteria-From-Selected-Genetic-and-Evolutionary-Aspects-A-Review.pdf
Gaiarsa, S., Batisti Biffignandi, G., Esposito, E. P., Castelli, M., Jolley, K. A., Brisse, S., … Zarrilli, R. (2019). Comparative analysis of the two Acinetobacter baumannii multilocus sequence typing (MLST) schemes. Frontiers in Microbiology, 10, 930. https://www.frontiersin.org/articles/10.3389/fmicb.2019.00930/full
Geravand, M., Erfani, Y., Nematpour, N., Khosravani, M., Rahimnia, R., & Adabi, M. (2024). Nanoarchitectonics of aptamer-based electrochemical biosensor utilizing electrospun carbon nanofibers and gold nanoparticles for Acinetobacter baumannii detection. Microchemical Journal, 200, 110437.
https://www.sciencedirect.com/science/article/pii/S0026265X24005496
Goic-Barisic, I., Kovacic, A., Medic, D., Jakovac, S., Petrovic, T., Tonkic, M., … Hrenovic, J. (2021). Endemicity of OXA-23 and OXA-72 in clinical isolates of Acinetobacter baumannii from three neighbouring countries in Southeast Europe. Journal of Applied Genetics, 62, 353–359. https://link.springer.com/article/10.1007/s13353-021-00612-9
Hamidian, M., & Nigro, S. J. (2019). Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microbial Genomics, 5(10), e000306. https://www.microbiologyresearch.org/content/journal/mgen/10.1099/mgen.0.000306
Thomas Benoita,b, Michel Cloutiera, Rhonda Schopc, Mark W. Lowerisond , Izhar U.H. Khana,⁎ Comparative assessment of growth media and incubation conditions for enhanced recovery and isolation of Acinetobacter baumannii from aquatic matrices Journal of Microbiological Methods. vol 176 September 2020 106023. https://doi.org/10.1016/j.mimet.2020.106023
Howard, A., O’Donoghue, M., Feeney, A., & Sleator, R. D. (2012). Acinetobacter baumannii: an emerging opportunistic pathogen. Virulence, 3(3), 243–250. https://www.tandfonline.com/doi/abs/10.4161/viru.19700
Jacobsson, S., Cole, M. J., Schröder, D., van Rensburg, M. J., Day, M., Ködmön, C., … Golparian, D. (2025). Antimicrobial resistance in Neisseria gonorrhoeae and its risk groups in 23 European countries in 2022 within the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP): a retrospective observational study. The Lancet Regional Health–Europe, 54. https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(25)00110-3/fulltext
Jiang, Y., Ding, Y., Wei, Y., Jian, C., Liu, J., & Zeng, Z. (2022). Carbapenem-resistant Acinetobacter baumannii: A challenge in the intensive care unit. Frontiers in Microbiology, 13, 1045206. https://www.frontiersin.org/articles/10.3389/fmicb.2022.1045206/full
Kanamori, H., Rutala, W. A., Sickbert-Bennett, E. E., & Weber, D. J. (2023). Role of the contaminated environment in transmission of multidrug-resistant organisms in nursing homes and infection prevention. American Journal of Infection Control, 51(11), A151–A157.
https://www.sciencedirect.com/science/article/pii/S0196655323000032
König, P., Wilhelm, A., Schaudinn, C., Poehlein, A., Daniel, R., Widera, M., … Müller, V. (2023). The VBNC state: a fundamental survival strategy of Acinetobacter baumannii. mBio, 14(5), e02139-23. https://journals.asm.org/doi/abs/10.1128/mbio.02139-23
Le, D. Q., Nguyen, T. T., Nguyen, C. H., Ho, T. H., Vo, N. S., Nguyen, T., … Nguyen, S. H. (2024). AMRomics: a scalable workflow to analyze large microbial genome collections. BMC Genomics, 25(1), 709.
https://link.springer.com/article/10.1186/s12864-024-10620-8
Li, X., Wu, Z., Dang, C., Zhang, M., Zhao, B., Cheng, Z., … Xia, Y. (2020). Aerosol antibiotic resistance gene dissemination among hospital departments by culture-facilitated comparative metagenomics. Research Square Preprint. https://assets-eu.researchsquare.com/files/rs-10962/v1_covered.pdf
Loveday, H. P., Wilson, J. A., Pratt, R. J., Golsorkhi, M., Tingle, A., Bak, A., … Wilcox, M. (2014). epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. Journal of Hospital Infection, 86, S1–S70. https://www.sciencedirect.com/science/article/pii/S0195670113600122
McConnell, M. J., Actis, L., & Pachón, J. (2013). Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models. FEMS Microbiology Reviews, 37(2), 130–155. https://academic.oup.com/femsre/article-abstract/37/2/130/622880
Michelon, D., Félix, B., Vingadassalon, N., Mariet, J. F., Larsson, J. T., Møller-Nielsen, E., & Roussel, S. (2015). PFGE standard operating procedures for Listeria monocytogenes: harmonizing the typing of food and clinical strains in Europe. Foodborne Pathogens and Disease, 12(3), 244–252. https://www.liebertpub.com/doi/abs/10.1089/fpd.2014.1877
Munoz-Price, L. S., & Weinstein, R. A. (2008). Acinetobacter infection. New England Journal of Medicine, 358(12), 1271–1281. https://www.nejm.org/doi/abs/10.1056/NEJMra070741
Müller, C., Reuter, S., Wille, J., Xanthopoulou, K., Stefanik, D., Grundmann, H., … Seifert, H. (2023). A global view on carbapenem-resistant Acinetobacter baumannii. mBio, 14(6), e02260-23. https://journals.asm.org/doi/abs/10.1128/mbio.02260-23
Nasrumminallah, M., & Rehan, F. (2024). Laboratory Information Management System (LIMS) Analysis: A Lucrative Tool to Support the Control of Antimicrobial Resistance (AMR). In Antimicrobial Stewardship—New Insights. IntechOpen. https://www.intechopen.com/chapters/88566
Nerandzic, M. M., Cadnum, J. L., Pultz, M. J., & Donskey, C. J. (2010). Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms. BMC Infectious Diseases, 10, 197. https://link.springer.com/article/10.1186/1471-2334-10-197
Nocera, F. P., Attili, A. R., & De Martino, L. (2021). Acinetobacter baumannii: its clinical significance in human and veterinary medicine. Pathogens, 10(2), 127. https://www.mdpi.com/2076-0817/10/2/127
O’Neill, J. (2016). Tackling drug-resistant infections globally: final report and recommendations. https://www.cabidigitallibrary.org/doi/full/10.5555/20173071720
Otter, J. A., Yezli, S., Perl, T. M., Barbut, F., & French, G. L. (2013). The role of ‘no-touch’ automated room disinfection systems in infection prevention and control. Journal of Hospital Infection, 83(1), 1–13. https://www.sciencedirect.com/science/article/pii/S0195670112003362
Otter, J. A., Yezli, S., & French, G. L. (2011). The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infection Control & Hospital Epidemiology, 32(7), 687–699. https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/role-played-by-contaminated-surfaces-in-the-transmission-of-nosocomial-pathogens/F11A873DDEA8B75C0C79AADC78180775
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clinical Microbiology Reviews, 21(3), 538–582.
https://journals.asm.org/doi/abs/10.1128/cmr.00058-07
Quainoo, S., Coolen, J. P., van Hijum, S. A., Huynen, M. A., Melchers, W. J., van Schaik, W., & Wertheim, H. F. (2017). Whole-genome sequencing of bacterial pathogens: the future of nosocomial outbreak analysis. Clinical Microbiology Reviews, 30(4), 1015–1063.
https://journals.asm.org/doi/abs/10.1128/cmr.00016-17
Quick, J., Ashton, P., Calus, S., Chatt, C., Gossain, S., Hawker, J., … Loman, N. J. (2015). Rapid draft sequencing and real-time nanopore sequencing in a hospital outbreak of Salmonella. Genome Biology, 16, 67.
https://link.springer.com/article/10.1186/s13059-015-0677-2
Rizzo, L., Manaia, C., Merlin, C., Schwartz, T., Dagot, C., Ploy, M. C., … Fatta-Kassinos, D. (2013). Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: a review. Science of the Total Environment, 447, 345–360.
https://www.sciencedirect.com/science/article/pii/S0048969713000429
Robinson, T. P., Bu, D. P., Carrique-Mas, J., Fèvre, E. M., Gilbert, M., Grace, D., … Woolhouse, M. E. (2016). Antibiotic resistance is the quintessential One Health issue. Transactions of the Royal Society of Tropical Medicine and Hygiene, 110(7), 377–380. https://academic.oup.com/trstmh/article-abstract/110/7/377/2588524
Sax, H., Allegranzi, B., & Pittet, D. (2017). My five moments for hand hygiene. In Hand Hygiene: A Handbook for Medical Professionals (pp. 134–143). https://onlinelibrary.wiley.com/doi/abs/10.1002/9781118846810.ch20
Schuetz, P., Muller, B., Christ-Crain, M., Stolz, D., Tamm, M., Bouadma, L., … Briel, M. (2013). Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Evidence-Based Child Health: A Cochrane Review Journal, 8(4), 1297–1371. https://onlinelibrary.wiley.com/doi/abs/10.1002/ebch.1927
Sharma, A., & Gaind, R. (2021). Development of loop-mediated isothermal amplification assay for detection of clinically significant members of Acinetobacter calcoaceticus–baumannii complex and associated carbapenem resistance. Frontiers in Molecular Biosciences, 8, 659256. https://www.frontiersin.org/articles/10.3389/fmolb.2021.659256/full
Shrivastava, S. R., Shrivastava, P. S., & Ramasamy, J. (2018). World Health Organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Journal of Medical Society, 32(1), 76–77. https://journals.lww.com/jmso/fulltext/2018/32010/World_health_organization_releases_global_priority.16.aspx
Snitkin, E. S., Zelazny, A. M., Montero, C. I., Stock, F., Mijares, L., NISC Comparative Sequence Program, … Thomas, P. (2011). Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii. Proceedings of the National Academy of Sciences, 108(33), 13758–13763. https://www.pnas.org/doi/abs/10.1073/pnas.1104404108
Snitkin, E. S., Zelazny, A. M., Thomas, P. J., Stock, F., NISC Comparative Sequencing Program, Henderson, D. K., … Segre, J. A. (2012). Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Science Translational Medicine, 4(148), 148ra116. https://www.science.org/doi/abs/10.1126/scitranslmed.3004129
Tacconelli, E., De Angelis, G., Cataldo, M. A., Pozzi, E., & Cauda, R. (2008). Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy, 61(1), 26–38. https://academic.oup.com/jac/article-abstract/61/1/26/911115
Tang, K. L., Caffrey, N. P., Nóbrega, D. B., Cork, S. C., Ronksley, P. E., Barkema, H. W., … Ghali, W. A. (2017). Restricting the use of antibiotics in food-producing animals and its associations with antibiotic resistance in food-producing animals and human beings: a systematic review and meta-analysis. The Lancet Planetary Health, 1(8), e316–e327. https://www.thelancet.com/journals/lancet/article/PIIS2542-5196(17)30141-9/fulltext
Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H., & Swaminathan, B. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology, 33(9), 2233–2239. https://journals.asm.org/doi/pdf/10.1128/jcm.33.9.2233-2239.1995
Tomaras, A. P., Dorsey, C. W., Edelmann, R. E., & Actis, L. A. (2003). Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology, 149(12), 3473–3484. https://www.microbiologyresearch.org/content/journal/micro/10.1099/mic.0.26541-0
Weber, D. J., Rutala, W. A., Miller, M. B., Huslage, K., & Sickbert-Bennett, E. (2010). Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. American Journal of Infection Control, 38(5), S25–S33. https://www.sciencedirect.com/science/article/pii/S0196655310004086
Walsh, T. R. (2018). A one-health approach to antimicrobial resistance. Nature Microbiology, 3(8), 854–855. https://www.nature.com/articles/s41564-018-0208-5
Weber, D. J., Anderson, D., & Rutala, W. A. (2013). The role of the surface environment in healthcare-associated infections. Current Opinion in Infectious Diseases, 26(4), 338–344.
Wilharm, G., Skiebe, E., Higgins, P. G., Poppel, M. T., Blaschke, U., Leser, S., … Jerzak, L. (2017). Relatedness of wildlife and livestock avian isolates of the nosocomial pathogen Acinetobacter baumannii to lineages spread in hospitals worldwide. Environmental Microbiology, 19(10), 4349–4364. https://ami-journals.onlinelibrary.wiley.com/doi/pdf/10.1111/1462-2920.13931
Woolhouse, M., Ward, M., Van Bunnik, B., & Farrar, J. (2015). Antimicrobial resistance in humans, livestock and the wider environment. Philosophical Transactions of the Royal Society B: Biological Sciences, 370(1670), 20140083. https://royalsocietypublishing.org/doi/abs/10.1098/rstb.2014.0083
World Health Organization. (2022). Global antimicrobial resistance and use surveillance system (GLASS) report 2022. WHO. https://books.google.com/books?hl=en&lr=&id=dHsOEQAAQBAJ&oi=fnd&pg=PR4
Ghaith F. Al-Ryahneh1 & Suha Al- Muhaissen1Special Contribution Report of a Workshop on Antimicrobial Resistance (AMR) at the University of Jordan, December 12–14, 2024Jordan Medical Journal, Volume 59, No.1 2025 DOI: https://doi.org/10.35516/jmj.v59i1.3869
